# Beta Bionics (BBNX) — News

BBNX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bbnx/news

## Recent headlines

- [Beta Bionics, Inc.: Truist Securities raises target price to $28 from $23](https://www.ainvest.com/news/beta-bionics-truist-securities-raises-target-price-28-23-2609) — AInvest Wire, Sep 24, 2026
- [Beta Bionics announces closing of $172.5 million public offering of common stock](https://www.ainvest.com/news/beta-bionics-announces-closing-172-5-million-public-offering-common-stock-2609) — AInvest Wire, Sep 17, 2026
  Beta Bionics has announced the successful closing of a $172.5 million public offering of its common stock. The offering, which was initially proposed as a $125 million raise, was upsized to meet strong investor demand . The funds will be allocated toward research and development, commercial…
- [Beta Bionics prices offering of 7.7M shares at $17.25/shr](https://www.ainvest.com/news/beta-bionics-prices-offering-7-7m-shares-17-25-shr-2609) — AInvest Wire, Sep 16, 2026
  Beta Bionics Inc. has priced its public offering of 7.7 million shares at $17.25 per share [1]. The offering, which was announced earlier this week, is part of the company’s strategy to raise capital for ongoing research and development initiatives. The total offering size amounts to approximately…
- [Beta Bionics prices offering of stock and pre-funded warranties](https://www.ainvest.com/news/beta-bionics-prices-offering-stock-pre-funded-warranties-2609) — AInvest Wire, Sep 16, 2026
- [Beta Bionics, - To use proceeds for mint commercialization, manufacturing, R&D, and working capital](https://www.ainvest.com/news/beta-bionics-proceeds-mint-commercialization-manufacturing-working-capital-2609) — AInvest Wire, Sep 15, 2026
  Beta Bionics, Inc. has announced plans to allocate proceeds from recent financing activities toward the commercialization of its Mint™ product, as well as for manufacturing, research and development (R&D), and working capital purposes. The company recently received FDA clearance for Mint™, marking…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).